Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PhytoQuest is a biotechnology company based in Wales that specializes in the discovery and development of bioactive natural products, with a primary focus on iminosugars. These small molecule carbohydrate analogues are derived from plants and fungi and possess significant potential as therapeutic agents due to their ability to modulate glycosidase and glycosyltransferase enzymes. The company's research spans multiple sectors, including pharmaceuticals for viral infections and metabolic disorders, as well as high-value ingredients for the nutraceutical and cosmetic industries. PhytoQuest operates primarily through a discovery and licensing model, leveraging its proprietary library of rare natural compounds to partner with larger organizations for clinical development. Their expertise in glycobiology allows them to identify compounds that can interfere with viral protein folding or manage glucose absorption.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phytoquest.